NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 4.95% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.84% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.41% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.36% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.33% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.23% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.02% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 3.97% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.93% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.80% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.80% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 3.41% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| NEU | Neuren Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.89% |